Mesco Pharmaceuticals Ltd. reported unaudited earnings results for the second quarter and six months ended September 30, 2018. For the quarter, the company reported loss before exceptional items and tax finance costs was INR 3,571,742 compared INR 126,439 a year ago. Loss before tax was INR 3,571,742 compared to INR 126,439 a year ago. Loss for the period was INR 3,571,742 compared to INR 126,439 a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.18 compared to INR 0.01 a year ago. For the six months, the company reported loss before exceptional items and tax finance costs was INR 3,870,942 compared INR 636,944 a year ago. Loss before tax was INR 3,870,942 compared to INR 636,944 a year ago. Loss for the period was INR 3,870,942 compared to INR 636,944 a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.19 compared to INR 0.03 a year ago.